Roles of beta-catenin overexpression and adenomatous polyposis coli mutation in head and neck cancer

4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Beta-catenin is an undercoat protein of cadherin, a cellular adhesion molecule. Beta-catenin also functions as a transcriptional activator downstream of the Wnt signaling pathway. Intracellular beta-catenin is regulated by the formation of a complex with APC (adenomatous polyposis coli) protein. The activation of this pathway by stabilization with beta-catenin has been shown to be an important step in the development of colorectal carcinoma, which is mainly caused by inactivating mutations in the APC tumor suppressor gene or by activating mutations in exon 3 of the beta-catenin gene. This study was conducted to clarify the contribution of beta-catenin accumulation and the mutation of the beta-catenin gene to the carcinogenesis of head and neck cancer. Beta-catenin accumulation was examined immunohistochemically in 49 frozen or formalin-fixed, paraffin-embedded samples of head and neck tumors. We also performed a direct sequence analysis of APC and beta-catenin to examine the cause of beta-catenin accumulation. Genomic DNA was extracted and purified from fresh tissue samples of head and neck cancers. We examined the APC mutation cluster region in 15 samples and analyzed beta-catenin exon 3 mutations in 31 cases. Twelve out of 49 (24.5%) cases exhibited beta-catenin accumulation in our histochemical study. The 5 year survival rate was 0% in the beta-catenin accumulation group, compared to 50% in the non-accumulation group, (p<0.01). This finding strongly suggests that beta-catenin may play an important role in the carcinogenesis or progression of head and neck cancer. One of the 15 cases exhibited an APC missense mutation that led to the replacement of amino acids; this case died in 12 months. Regarding the beta-catein mutation, non of the 31 samples exhibited a gene mutation in beta-catenin exon 3. Thus, the rate of APC and beta-catenin mutation in head and neck cancer may be very low.

References Powered by Scopus

Lessons from hereditary colorectal cancer

4385Citations
N/AReaders
Get full text

Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC

3640Citations
N/AReaders
Get full text

Constitutive transcriptional activation by a β-catenin-Tcf complex in APC(-/-) colon carcinoma

3024Citations
N/AReaders
Get full text

Cited by Powered by Scopus

β-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck

37Citations
N/AReaders
Get full text

Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma

28Citations
N/AReaders
Get full text

Multidimensional Mutational Profiling of the Indian HNSCC Sub-Population Provides IRAK1, a Novel Driver Gene and Potential Druggable Target

9Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Takei, S., Ueno, Y., Yoda, J., Tamura, S., Hotomi, M., Fujihara, K., … Yamanaka, N. (2003). Roles of beta-catenin overexpression and adenomatous polyposis coli mutation in head and neck cancer. Journal of Otolaryngology of Japan, 106(6), 692–699. https://doi.org/10.3950/jibiinkoka.106.692

Readers over time

‘13‘14‘18‘20‘21‘2400.751.52.253

Readers' Seniority

Tooltip

Professor / Associate Prof. 2

67%

Researcher 1

33%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 2

67%

Neuroscience 1

33%

Save time finding and organizing research with Mendeley

Sign up for free
0